Aileron Therapeutics to Host Key Opinion Leader Event on : c

Panel discussion will highlight LTI-03, Aileron’s novel Caveolin-1-related peptide, for the treatment of idiopathic pulmonary fibrosis...

Related Keywords

Tejaswini Kulkarni , Fernandoj Martinez , Agaplesion Evang , Aileron Therapeutics Inc , Rare Lung Diseases At Justus Liebig University , Treating Idiopathic Pulmonary , Critical Care Medicine Division , Weill Cornell , Associate Professor , Critical Care Medicine , Interstitial Lung Disease Program , Senior Physician , Intensive Care Medicine , Chief Physician , Internal Intensive Care Medicine , Central Hesse Hospital , Rare Lung Diseases , Justus Liebig , Orphan Drug Designation , Fast Track Designation , Media Contact , Nasdaq Alrn , Aileron Therapeutics , Nc ,